Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.

Immunosuppressants are used ubiquitously post-liver transplantation to prevent allograft rejection. However their effects on hepatocytes are unknown. Experimental data from non-liver cells indicate that immunosuppressants may promote cell death thereby driving an inflammatory response that promotes...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Eu Jin Lim, Ruth Chin, Ueli Nachbur, John Silke, Zhiyuan Jia, Peter W Angus, Joseph Torresi
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Public Library of Science (PLoS) 2015-01-01
Σειρά:PLoS ONE
Διαθέσιμο Online:http://europepmc.org/articles/PMC4577231?pdf=render
_version_ 1828838260071202816
author Eu Jin Lim
Ruth Chin
Ueli Nachbur
John Silke
Zhiyuan Jia
Peter W Angus
Joseph Torresi
author_facet Eu Jin Lim
Ruth Chin
Ueli Nachbur
John Silke
Zhiyuan Jia
Peter W Angus
Joseph Torresi
author_sort Eu Jin Lim
collection DOAJ
description Immunosuppressants are used ubiquitously post-liver transplantation to prevent allograft rejection. However their effects on hepatocytes are unknown. Experimental data from non-liver cells indicate that immunosuppressants may promote cell death thereby driving an inflammatory response that promotes fibrosis and raises concerns that a similar effect may occur within the liver. We evaluated apoptosis within the liver tissue of post-liver transplant patients and correlated these findings with in vitro experiments investigating the effects of immunosuppressants on apoptosis in primary hepatocytes.Hepatocyte apoptosis was assessed using immunohistochemistry for M30 CytoDEATH and cleaved PARP in human liver tissue. Primary mouse hepatocytes were treated with various combinations of cyclosporine, tacrolimus, sirolimus, or MMF. Cell viability and apoptosis were evaluated using crystal violet assays and Western immunoblots probed for cleaved PARP and cleaved caspase 3.Post-liver transplant patients had a 4.9-fold and 1.7-fold increase in M30 CytoDEATH and cleaved PARP compared to normal subjects. Cyclosporine and tacrolimus at therapeutic concentrations did not affect hepatocyte apoptosis, however when they were combined with MMF, cell death was significantly enhanced. Cell viability was reduced by 46% and 41%, cleaved PARP was increased 2.6-fold and 2.2-fold, and cleaved caspase 3 increased 2.2-fold and 1.8-fold following treatment with Cyclosporine/MMF and Tacrolimus/MMF respectively. By contrast, the sirolimus/MMF combination did not significantly reduce hepatocyte viability or promote apoptosis.Commonly used immunosuppressive drug regimens employed after liver transplantation enhance hepatocyte cell death and may thus contribute to the increased liver fibrosis that occurs in a proportion of liver transplant recipients.
first_indexed 2024-12-12T18:58:55Z
format Article
id doaj.art-f61b51a8725f43a9833ddd56cd7e706a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T18:58:55Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f61b51a8725f43a9833ddd56cd7e706a2022-12-22T00:15:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013852210.1371/journal.pone.0138522Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.Eu Jin LimRuth ChinUeli NachburJohn SilkeZhiyuan JiaPeter W AngusJoseph TorresiImmunosuppressants are used ubiquitously post-liver transplantation to prevent allograft rejection. However their effects on hepatocytes are unknown. Experimental data from non-liver cells indicate that immunosuppressants may promote cell death thereby driving an inflammatory response that promotes fibrosis and raises concerns that a similar effect may occur within the liver. We evaluated apoptosis within the liver tissue of post-liver transplant patients and correlated these findings with in vitro experiments investigating the effects of immunosuppressants on apoptosis in primary hepatocytes.Hepatocyte apoptosis was assessed using immunohistochemistry for M30 CytoDEATH and cleaved PARP in human liver tissue. Primary mouse hepatocytes were treated with various combinations of cyclosporine, tacrolimus, sirolimus, or MMF. Cell viability and apoptosis were evaluated using crystal violet assays and Western immunoblots probed for cleaved PARP and cleaved caspase 3.Post-liver transplant patients had a 4.9-fold and 1.7-fold increase in M30 CytoDEATH and cleaved PARP compared to normal subjects. Cyclosporine and tacrolimus at therapeutic concentrations did not affect hepatocyte apoptosis, however when they were combined with MMF, cell death was significantly enhanced. Cell viability was reduced by 46% and 41%, cleaved PARP was increased 2.6-fold and 2.2-fold, and cleaved caspase 3 increased 2.2-fold and 1.8-fold following treatment with Cyclosporine/MMF and Tacrolimus/MMF respectively. By contrast, the sirolimus/MMF combination did not significantly reduce hepatocyte viability or promote apoptosis.Commonly used immunosuppressive drug regimens employed after liver transplantation enhance hepatocyte cell death and may thus contribute to the increased liver fibrosis that occurs in a proportion of liver transplant recipients.http://europepmc.org/articles/PMC4577231?pdf=render
spellingShingle Eu Jin Lim
Ruth Chin
Ueli Nachbur
John Silke
Zhiyuan Jia
Peter W Angus
Joseph Torresi
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
PLoS ONE
title Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
title_full Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
title_fullStr Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
title_full_unstemmed Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
title_short Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
title_sort effect of immunosuppressive agents on hepatocyte apoptosis post liver transplantation
url http://europepmc.org/articles/PMC4577231?pdf=render
work_keys_str_mv AT eujinlim effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT ruthchin effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT uelinachbur effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT johnsilke effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT zhiyuanjia effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT peterwangus effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation
AT josephtorresi effectofimmunosuppressiveagentsonhepatocyteapoptosispostlivertransplantation